Breast Cancer
Breast cancer is a type of cancer that forms in the cells of the breasts, and it can affect both men and women. Symptoms may include lumps in the breast, changes in breast shape or size, and unusual discharge from the nipple.
Breast Cancer Treatment: I-BCT-1 Study
We are exploring how genetic changes in breast tumors can help select the best treatment options for patients. This study includes patients with neoadjuvant and metastatic breast cancer to improve therapy outcomes.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a man or woman with breast cancer that is HER2-negative?
- Is your cancer measurable on imaging (larger than 20 mm)?
- Is your performance status (how well you can do daily activities) 2 or lower?
- Have you had chemotherapy for breast cancer in the last 24 months?
- Have you had any other cancer in the last five years, except for certain skin cancers?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Carbo-Cell
Carbomedac
Carboplan
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Oslo University Hospital HF
Cancer Department
Oslo, Norway
Sponsor: Oslo University Hospital HF
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.